Welcome to World Class Retina Care

Our practice was established in 1980 in central Phoenix. Since then, we have grown to include more than 35 locations throughout Arizona, providing improved access to the highest quality medical care. We are proud to have become Arizona’s largest and most experienced ophthalmology practice focused specifically on the diagnosis and management of the retina and vitreous.

At RCA, we believe in providing you with professional, attentive, and personal care while utilizing the latest technology and treatments. We accept new patients every day, and urgent or emergency referrals are seen the same day.

Find Your Location Today

March Is Workplace Eye Safety Wellness Month


Each year, nearly 25,000 Americans visit the emergency room due to a workplace eye injury. During Workplace Eye Wellness Month this March, Retinal Consultants of Arizona reminds employers and workers about the importance of wearing certified and approved eye protection.

Latest News From RCA

EUROTIMES – Innovation in Retina Surgery – Dr. Pravin U. Dugel Interview

INNOVATION IN RETINA SURGERY: Technological innovation is crucial to the continued improvement 
of vitreoretinal surgery. Leigh Spielberg Posted: EUROTIMES – Thursday, March 1, 2018 Technological innovation is crucial to the continued improvement of vitreoretinal surgery. This was abundantly apparent during the RetinaTech Bio-Engineering Session during the 17th EURETINA Congress in Barcelona, Spain. Subtitled “Where Surgery… Read More »

Retinal Research Institute: New FDA-Approved Stem Cell Research Study

Information for Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration – An Experimental Treatment of Severe Vision Loss from Advanced Dry Age-Related Macular Degeneration. What is the Investigational treatment? This investigational treatment includes using an implant to replace some of the cells in the retina that have been lost or damaged due to… Read More »

Dr. Pravin U. Dugel – Modern Retina from Ophthalmology Times

These novel strategies may change DME treatment paradigm By: Michelle Dalton, ELS; Reviewed by Pravin U. Dugel, MD There is no denying that the anti-vascular endothelial growth factor A (anti-VEGF-A) monotherapy has “absolutely revolutionized our treatment of diabetic macular edema (DME).” However, there is a subset of patients in whom the anti-VEGFs are not an… Read More »